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Abstract
Background: The choice between paper data collection methods and electronic data collection
(EDC) methods has become a key question for clinical researchers. There remains a need to
examine potential benefits, efficiencies, and innovations associated with an EDC system in a multi-
center medical record review study.
Methods: A computer-based automated menu-driven system with 658 data fields was developed
for a cohort study of women aged 65 years or older, diagnosed with invasive histologically
confirmed primary breast cancer (N = 1859), at 6 Cancer Research Network sites. Medical record
review with direct data entry into the EDC system was implemented. An inter-rater and intra-rater
reliability (IRR) system was developed using a modified version of the EDC.
Results: Automation of EDC accelerated the flow of study information and resulted in an efficient
data collection process. Data collection time was reduced by approximately four months compared
to the project schedule and funded time available for manuscript preparation increased by 12
months. In addition, an innovative modified version of the EDC permitted an automated evaluation
of inter-rater and intra-rater reliability across six data collection sites.
Conclusion: Automated EDC is a powerful tool for research efficiency and innovation, especially
when multiple data collection sites are involved.
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Background
Advances in computer technology have produced readily
available, low cost, portable, highly efficient computer
equipment. Coupled with the transition of medical docu-
mentation from paper to electronic storage, computer
technology has helped to facilitate changes in data collec-
tion for clinical research. The choice between paper data
collection methods or automated electronic data collec-
tion (EDC) methods has become a key design question
for clinical researchers. However, the literature on elec-
tronic data collection is sparse. We identified only a few
published reports that have compared EDC with paper
data collection, or more generally addressed EDC for
research purposes. [1-6]
Researchers have turned to electronic methods of data col-
lection to improve the quality of data and to conduct
research more effectively and efficiently. Standardizing
the data collection process to maintain cross-site data con-
sistency remains a challenge in multi-center studies.
Given the required investment in hardware, software, and
training, researchers must consider the advantages and
disadvantages of adopting EDC.[7] Some of the docu-
mented advantages of EDC are: (1) integration of mixed
data types by preloading electronically available data and
manually inputting non-electronic data; (2) programmed
error checking by transparent decision algorithms; (3)
directed data entry by use of pick lists, forced data entry,
and automated skip patterns; (4) automated validation
procedures such as data reliability and data range checks;
(5) increased opportunity for innovation; and (6) reduced
time from study implementation to manuscript submis-
sion. [1-8] The disadvantages are: (1) extensive time and
programming needed to develop EDC systems; (2) equip-
ment costs; and (3) lack of ability to verify miscoded data
against paper records, once data have been entered. [1-8]
Despite these disadvantages, EDC offers promise for inte-
grating existing data for multi-site longitudinal studies
with flexibility, innovation, and less effort than that
required by traditional paper methods. In addition, sub-
sequent systems can be developed from the first system
more efficiently and at lower cost.[8]
We report on our experience with an EDC system
designed to collect data for a multi center breast cancer
study, and an innovative method to assess cross-site data
consistency with a subsequent system automating inter-
rater/intra-rater reliability strategy.
Methods
Cohort ascertainment and data collection processes have
been described elsewhere.[9] In brief, we identified poten-
tially eligible subjects for inclusion in a cohort study from
electronic databases at six of the Cancer Research Network
(CRN) health care delivery systems: Group Health, Wash-
ington; Kaiser Permanente Southern California; Lovelace,
New Mexico; Henry Ford Health System, Michigan;
Health Partners, Minnesota; and Fallon Community
Health Plan, Massachusetts. The CRN is a consortium of
healthcare delivery systems, funded by the National Can-
cer Institute to increase the effectiveness of preventive,
curative and supportive interventions that span the natu-
ral history of major cancers.
Women aged 65 years or older and diagnosed with pri-
mary, histologically confirmed, early stage unilateral
breast cancer between January 1, 1990 and December 31,
1994 were eligible for inclusion in the study. Before the
start of medical record-based data collection, we collected
electronically demographic, tumor, treatment, and sur-
geon data from cancer registry, administrative, and clini-
cal databases at each site. Medical record abstractors
verified (at sites with cancer registries) or determined (at
sites without cancer registries) eligibility for each identi-
fied subject and collected any information that had not
been available from electronic sources. We abstracted data
from the date of initial diagnosis through death, disenroll-
ment from the health plan or 10 years post-diagnosis.
There were no control or intervention strategies in this
study. We describe the variability in electronically availa-
ble data across six sites and report efficiencies gained from
implementing an electronic data collection (EDC) instead
of the originally proposed paper-based data collection.
The EDC system
We developed a computer-based automated menu-driven
EDC system using Microsoft® Access 2000. The "back end"
of the system consisted of six tables that stored 658
exported data variables after completion of data abstrac-
tion in the "front end" of the system. The "front end" of
the system was organized into five forms for collecting
information on (1) eligibility, patient characteristics,
tumor characteristics, and treatment, (2) diagnosis and
treatment of recurrence and second primary cancer, (3)
comorbidity at three time points, (4) surveillance testing
for recurrent breast cancer after completing primary ther-
apy, and (5) mammography screening. All forms were
menu-driven, in a tabular format (as shown in Figure 1),
and linked by a unique study subject identification (ID)
number. Each site maintained a Microsoft® Excel file that
linked each subject's study number in the EDC to the sub-
ject's original medical record number to allow local access
to electronic data and medical records as needed. Study
specific queries and macros were programmed to allow
for toggling between the forms, verification of input data,
final checking for completeness of the data collected, and
for export into the "back-end" database. Consistent with
data use agreements between Boston Medical Center and
the data collection sites, and per HIPAA agreements, per-
sonal identifiers such as surgeons' names and patients'
BMC Medical Research Methodology 2007, 7:23 http://www.biomedcentral.com/1471-2288/7/23
Page 3 of 8
(page number not for citation purposes)
day of birth were deleted before exporting into the "back-
end" database.
For each site, we preloaded into the EDC all study ID
numbers for potentially eligible subjects along with all
electronically available data. Each site-specific EDC sys-
tem was configured for use on individual computers. To
ensure cross-site consistency, one person trained medical
record abstractors at each participating site using local, de-
identified medical records as sample records. For
enhanced efficiency a 10% sampling scheme was imple-
mented to capture a sub-sample of the stage I, non-His-
panic White, less than 80 years age group at Kaiser
Permanente Southern California, the largest site.
To begin the abstraction, the abstractor chose the subject
ID from a pull down list on the Demographic, Breast Can-
cer and Treatment Form and all electronic data available
for this ID would fill the corresponding data fields in the
electronic abstraction forms. Each abstraction began with
verification of the eligibility criteria, allowing in one step
the abstractor to continue if further record abstraction was
indicated or to stop immediately and move on to the next
case. Upon confirmation of eligibility, stage, age and race,
if the sampling quota had been met for the specified
group, the abstractor was prompted to move on to the
next subject. The EDC operated on the premise that all
cases were in the process of completion, thereby allowing
editing of all pre-filled data elements. Extensive quality
control procedures were included in the EDC to minimize
abstraction error. These procedures included (1) range
checks for dates and value responses, (2) logic checks
prompting the abstractor to verify the answer if it was
either an out-of-range value or the response was not feasi-
ble given other clinical information, and (3) command
buttons with embedded coding information to assist in
Screen shot of EDC data collection formFigure 1
Screen shot of EDC data collection form.
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data abstraction. The abstractor was able to set the abstrac-
tion to complete electronically only when all data and
logic checks had been satisfied. Once the data abstraction
was complete and passed the pre-programmed check for
completeness and logical consistency (Final Check), the
record was exported to the "back-end" database. At the
beginning of each month, all data were sent via a secure
internet transfer site to the data coordinating site at Bos-
ton Medical Center in electronic format. Data from each
electronic source within and across participating sites
were merged and cleaned at the data coordinating site in
preparation for analyses, using SAS statistical soft-
ware.[10]
The inter-/intra-rater reliability (IRR) system
We used a completely automated triple abstraction proc-
ess to incorporate quality controls to reduce inter- and
intra-site variability and to improve accuracy of data col-
lection. We developed a Microsoft® Access-based IRR sys-
tem using a modified version of the automated EDC
system. The IRR system contained a subset of 54 key data
elements (of 658 collected by the EDC), and was organ-
ized on a single form with tabular format to differentiate
five areas of interest for evaluating data reliability and
consistency: tumor characteristics, tumor treatment,
development of recurrence or second primary, comorbid-
ity, and surveillance mammography. The same range
checks, logic checks, and a final check for completion as
in the EDC system were programmed for these key varia-
bles. The IRR system contained in its "back end" tables the
data from original abstractions on five records for each
abstractor, randomly selected from records completed
three months prior to the IRR exercise. For re-abstractions,
record for each subject ID in the IRR system was pre-pop-
ulated with the same data that was preloaded into the
EDC system for the original medical record abstraction.
The key data elements were re-abstracted and entered
directly into the IRR system by the original abstractor (for
intra-rater reliability comparison) and by the site project
manager (for inter-rater reliability comparison). Upon
completion of all five records by an abstractor, the IRR sys-
tem compared re-abstracted data with the original abstrac-
tion and the pre-programmed reporting function in the
IRR system provided both the number of mismatches and
percent agreement for each record re-abstracted and by
sub-areas in the abstraction instrument. The IRR data were
sent by each site to the Boston Medical Center and pooled
to determine a study-wide reliability rate. Reports were
generated for each abstractor by subject ID, comparing the
re-abstractions to the original abstraction, aggregated by
content sections of compared data (tumor characteristics,
treatment, recurrence/second primary, comorbidity, and
surveillance mammography), and disaggregated into each
data element. The number of mismatches and percent
agreement were electronically calculated for all items by
subject ID and automatically displayed in three categories:
total, preloaded variables, and non-preloaded variables.
Data were shared with the abstractors to develop strategies
to reduce errors. IRR exercises were conducted once each
during the first and second halves of the data collection
period.
Results
The EDC system and a user manual with detailed coding
guide were developed concurrently over a 6-month period
at Boston Medical Center, the study data-coordinating
center. Both the EDC and the manual were tested at all
sites during the training sessions and the revised versions
were released one month later. Each site had 1 to 3
abstractors working on the study as well as a part time res-
ident programmer who was knowledgeable in Microsoft®
Access and SAS. Depending on where the medical records
were stored, data abstraction took place at multiple loca-
tions, up to 20 at one CRN site. Fifteen medical record
abstractors were trained to use the EDC system and subse-
quently evaluated with the IRR system.
There were varying amounts of electronic data available
from cancer registry and administrative databases for
preloading. Two non-registry sites had 5 data items avail-
able (age, birth-month, birth-year, potential diagnosis
date, end of follow-up date), whereas four registry sites
had 32 to 37 data items available. All electronically avail-
able data were sent in Microsoft® Excel, Access, or SAS for-
mat and merged to the "back end" database of the EDC
system.
Of 3,766 potential cases identified at 6 sites, electronic
data on 3,124 cases were preloaded into the EDC. The
remaining cases not included in the EDC were from Kaiser
Permanente Southern California where only 10% of the
younger than 80 years age, non-Hispanic white, stage I
cases were sampled. A sampling fraction of 50% was
implemented initially at the other 5 sites for the same sub-
group, however, based on sociodemographic and disease
characteristics necessary to meet our scientific goals, we
decided to enroll all identified cases at these sites. We were
able to implement and adjust sampling strategies by mod-
ification of the preloaded case lists. This real time adjust-
ment of sampling characteristics allowed us to
compensate during the data collection process.
Eligibility was confirmed for 1,859 cases and data collec-
tion was completed 18 months after release of EDC. There
were 49 cases (of 3,124 total preloaded) electronically
identified during the data collection process as missed
abstractions; 15 of those were found to be enrollment-eli-
gible and were subsquently abstracted. This process also
allowed us to capture data on why the abstraction was not
BMC Medical Research Methodology 2007, 7:23 http://www.biomedcentral.com/1471-2288/7/23
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done, thus providing information on potential selection
biases by site that otherwise would not have been availa-
ble. For example, we were able to examine the preloaded
characteristics of the 257 women with missing medical
records to determine whether this subgroup was different
from the 1,859 women who were included in the study
cohort.
We developed the IRR system directly from the EDC sys-
tem within a 2-month period. Programming time neces-
sary for development of the IRR system was reduced
substantially by the fact that all data structures in the IRR
system were derived from the original EDC system. Addi-
tionally, the menu-driven format of the IRR system, which
was based on the EDC system, was familiar to the abstrac-
tors and therefore easy and quick to implement with no
further training. Figure 2 displays an example of an IRR
report. All discrepancies in the reports were adjudicated at
the sites. We were able to identify from the IRR summary
table, as shown in Table 1, the possible inconsistency in
the abstraction of last known date of hormonal therapy.
This inconsistency prompted us to verify our data against
electronically available pharmacy data; the agreement was
over 83%.
Data cleaning after the completion of data collection con-
sisted of running a SAS program to identify inconsisten-
cies and coordinating with sites to resolve those
inconsistencies in four main areas: (1) side of the breast
(same vs. opposite breast from primary tumor) for recur-
rence and second primary cases; (2) follow-up time based
on the reason for end of follow-up (death, disenrollment
or completion of the 10 year study follow-up period); (3)
hormonal therapy start and stop dates; and (4) complete-
ness of surgeon data.
These efficiencies resulted in a substantial reduction in the
time needed for data management. The cumulative effect
was almost four months in reduced data collection time
compared to the original project schedule and almost 12
months reduction in time to manuscript preparation (Fig-
ure 3). Using the third project year salaries and time allo-
cations, we calculated the dollar savings at each of our six
data collection sites as the sum of two components: (1)
25% of budgeted project manager time for four months,
and (2) budgeted medical record abstractor time for four
months. With an additional 50% savings of budgeted data
analyst time for four months at the Boston Medical
Center, a savings of $72,000 in total from reduced data
collection costs across the six sites was estimated.
Discussion
Our experience with EDC resulted in significant research
advantages. The resource efficiency of the study was
derived directly from the development of our EDC system,
which combined medical record abstraction and data
entry into one step so that real-time data cleaning was
possible, and once the abstraction was complete, data
were immediately available for analysis. EDC allowed for
ease and efficiencies in data management between sites
Table 1: Summary of inter-rater reliability exercise for first half of data collection period, by type of data elements.
Site/Abstractor Tumor Treatment Treatment* w/o HT Date Recurrence Comorbidity Surveillance
A/1 3 6 2 3 2 12
A/2 1 6 3 1 3 19
B/3 3 6 2 7 0 11
B/4 1 9 4 6 4 10
B/5 0 5 1 1 0 15
C/6 0 5 2 0 1 27
C/7 0 3 2 1 5 13
D/8 2 5 3 1 3 15
D/10 5 7 6 0 0 5
D/11 1 7 3 2 1 11
E/12 2 7 5 1 3 8
F/15 8 7 2 0 1 7
#Disagreements 26 73 35 23 23 153
Total in section 420 360 360 360 1140 960
%Disagreement 6% 20% 10% 6% 2% 16%
*Excluding 38 Disagreements on Last Known Date of Hormonal Therapy
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and greatly increased overall study data flow. One benefit
was the ablity to monitor site-specific progress, sample
characterics, and cases deferred for later abstraction when
follow-up had not been completed. The component of the
EDC – which allowed deferred cases to be identified
before data abstraction began – eliminated the need to
order medical records twice. A second benefit was the abil-
ity to track missed abstractions. Before the start of data
collection, all of our study sites identified all potentially
eligible breast cancer cases through the use of electronic
databases. We loaded these lists of pre-identifed subjects
into the EDC system before data collection. As a result, the
total number of possible cases for each site was pre-deter-
mined and we were able to identify in a timely manner
and with ease the cases that were missed during the med-
ical record abstraction process, a step that would not have
been possible with full paper data collection.
With increasing availability of electronic data for research
and quality measurement, there is an increasing need for
ascertaining the accuracy of the data. This was reported by
Haque, et al. in relation to colorectal cancer screening.[11]
We found that various components of the EDC such as the
eligibility verification algorithm, the sampling algorithm,
the subject deferment algorithm and the final logic check
algorithm contributed to improve data collection effi-
ciency. In addition, Microsoft® Access-based programming
allowed data quality checks at various levels so that the
final data-cleaning step was minimized.
The most important innovation and efficiency associated
with our use of EDC was our ability to automate the IRR
process. We developed inter- and intra- reliability mod-
ules that allowed for interim feedback during data collec-
tion. This interim feedback cycle allowed real-time
corrective action during the data collection process based
on the IRR findings. Comparison of triple-abstractions
using electronic forms can be done rapidly, but requires
writing and testing programs within the structure of the
EDC database. We simplified identification of errors and
disagreements among abstractors and across sites by the
automated IRR process.
We have summarized in Table 2 the strengths of EDC and
highlighted items for consideration when deciding on use
of EDC versus paper data collection process. Length and
complexity of the data collection instrument, availability
of data (electronic versus paper medical record), and com-
plexity of the abstraction process (number of abstraction
locations, number of abstractors) are key elements to con-
sider during the decision making process. In addition,
costs associated with equipment, system development
and training need to be evaluated. When using EDC, not
only can overall record review cost be substantially
reduced, but it can also be carried out more efficiently.
Development, interim support, and troubleshooting are
simply the marginal costs, which can be offset by gains
from an EDC system.
Example of inter-rater reliability comparison reportFigure 2
Example of inter-rater reliability comparison report.
REPORT OF INTER-RATER COMPARISON 5/24/2004
ABSTRACTOR: DORIS (Fallon)
PTID: 10000 # MISMATCHES= 5 (AGREEMENT= 91 %) Preload: 0 ( 100 %) Non-Preload: 5 ( 89 %)
SECTION: 5.SURVEILLANCE/MAMMOGRAPHY
ORIGINAL VALUE ABSTRACTED 
MISMATCHED VARIABLE ABSTRACTED VALUE BY INTER-RATER
Q5_1CLI2 : Clinician ordering CBE RO S
Q5_1DAT2 : Date of CBE 7/12/1994 8/16/1994
Q5_2CLI2 : Clinician ordering Mammogram RO S
Q5_2DAT2 : Date of Mammography 8/17/1996 8/16/1996
Q5_2RES1 : MAMMOGRAM RESULT 3 4
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Any use of automated EDC for research purposes should
follow these guidelines. First, the electronic data collec-
tion form should be programmed only after designing,
piloting, and refining a paper version (pilot testing should
involve more than one abstractor and/or site when con-
ducting a multi-site study). This is a logical argument
based on the fact that multiple revisions to a data collec-
tion instrument are expected in a large scale research
study, especially when multiple sites are involved. Revi-
sions made on paper are cheaper than the programmer
time required for revisions to the EDC. Second, the data
collection form should be designed with the needs of the
data entry personnel in mind (e.g., structure the form in a
logical manner and make coding of responses as consist-
ent and straightforward as possible). Usability issues
related to EDC for clinical trials have been discussed by
Schmier, et. al., where it has been reported to contribute
to decreased costs, enhanced quality of the data, and min-
Table 2: Strengths and considerations of an electronic data collection system.
Strengths Considerations
Flexible with amount and type of site-specific electronic data available 
for preloading
May not be cost-effective if the data collection instrument is short, there 
is no mixed data type and/or number of data abstraction sites is small
Combines data abstraction and data entry into one step and allows for 
real-time data cleaning, so that data were immediately available for 
analysis
Resources needed for
1. system and manual development
2. training
3. hardware
4. software
Ease of managing data from multiple locations Skilled personnel needed at each site throughout the study period
Efficiency in data management from
1. automated algorithm for eligibility verification
2. integrated sampling scheme so that abstraction can be stopped once 
the sampling quota is reached
3. algorithm to defer abstraction until follow up period is complete
Readily allows for development of subsequent systems such as 
automated Inter-rater reliability process
Actual versus proposed study timelineFig re 3
Actual versus proposed study timeline.
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imized time to analysis.[12] Finally, a real time quality
control mechanism needs to be in place for assessing and
correcting data entry errors. The centralized generation of
monthly data-gathering provided early and ongoing indi-
cations of site-specific and generalized data collection
problems, thus providing opportunity for real time correc-
tive actions, such as obtaining an additional abstractor at
one site after observing a slower than expected rate of
abstract completion.
Conclusion
There is no more important aspect of research than to
acquire high quality data, which is highly reliant on the
quality of the data collection process. It follows, therefore,
that the design, development and quality assurance of
EDC should be given meticulous attention. Automated
EDC provides an efficient and innovative platform well
suited to allow researchers to capture, manage and report
on study progress and data quality. The flexibility of EDC
allows for multi-site as well as longitudinal studies. EDC
permits the seamless management of multiple workflows
and protocol algorithms, and the efficient deployment
and management of studies, which can be a critical suc-
cess factor in any research.
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